Keyphrases
Polyautoimmunity
80%
Systemic Lupus Erythematosus
72%
Colombia
64%
Autoimmune Disease
46%
Rheumatoid Arthritis
44%
Autoimmune Rheumatic Diseases
41%
Autoantibodies
41%
Autoimmune Thyroiditis
35%
Systemic Sclerosis
28%
Abatacept
27%
Real-world Experience
27%
Resilience
27%
Disease-based
27%
COVID-19
23%
Sjgren's Syndrome
23%
Colombians
22%
Colombian Patients
18%
Age of Onset
18%
New Taxonomy
18%
Meta-analysis
18%
Classification and Regression Tree
17%
Systematic Meta-analysis
15%
Latin America (LATAM)
15%
Cluster Analysis
15%
RAPID3
14%
Systemic Resilience
13%
Cluster Interaction
13%
Polymyalgia Rheumatica
13%
Autoimmune Neurological Disorders
13%
Immunobiology
13%
Group Teaching
13%
Poly(A)
13%
Teaching Excellence
13%
Faculty Development
13%
Outpatient Care
13%
Coffee Consumption
13%
Teacher Training
13%
Cytokine Imbalance
13%
Interleukin-6
13%
Kawasaki Disease
13%
Zika Outbreak
13%
Multisystem Inflammatory Syndrome in children (MIS-C)
13%
Predictive Models
13%
Patients with COVID-19
13%
Type I Diabetes
13%
Oxygen Partial Pressure
13%
Mortality Prediction
13%
Hashimoto's Thyroiditis
13%
Parasitosis
13%
Cigarette Smoking
13%
Immunology and Microbiology
Systemic Lupus Erythematosus
100%
Autoimmune Disease
71%
Inflammatory Arthritis
56%
Autoantibody
53%
Autoimmune Rheumatic Disease
41%
Autoimmune Thyroiditis
39%
Systemic Scleroderma
37%
Cytokine
36%
Abatacept
27%
Personal Experience
27%
Prevalence
26%
Autoimmunity
19%
Antiphospholipid Syndrome
13%
Rheumatic Polymyalgia
13%
La Antibody
13%
ELISA
13%
Interleukin 6
13%
Salivary Gland
13%
COVID-19
13%
Hashimoto's Thyroiditis
13%
Rheumatoid Factor
8%
Anti-Citrullinated Protein Antibody
8%
Antiphospholipid Antibody
8%
Quality Adjusted Life Year
6%
Rheumatic Disease
6%
Physical Activity
6%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
TNF Inhibitor
5%
Methotrexate
5%
Medicine and Dentistry
Diseases
38%
Rheumatoid Arthritis
37%
Inflammatory Arthritis
37%
Autoimmune Rheumatic Disease
27%
Personal Experience
27%
Abatacept
27%
Systemic Lupus Erythematosus
23%
Socioeconomic Status
17%
Systematic Review
17%
Routine Assessment of Patient Index Data
16%
Case-Control Study
15%
Polymyalgia Rheumatica
13%
Onset Age
13%
COVID-19
13%
Autoimmunity
13%
Neurologic Disease
13%
Kawasaki Disease
13%
Parasitic Disease
13%
Coronavirinae
13%
Serositis
13%
Immunology
13%
Zika virus
13%
Rheumatology
13%
Infection
13%
DAS28
13%
Disease Activity
10%
Anti-Citrullinated Protein Antibody
8%
Zika Fever
7%
Systemic Scleroderma
6%
Rheumatic Disease
6%
TNF Inhibitor
5%
Adverse Event
5%
Autoimmune Disease
5%
Methotrexate
5%
Rheumatoid Factor
5%
Cancer
5%
